Patent details
EP3962473 Title: FORMULATION FOR PAIN MANAGEMENT COMPRISING TETRAHYDROCANNABINOL (THC), CANNABICHROMENE (CBC) AND CANNABIDIOL (CBD) AT A GIVEN RATIO
Basic Information
- Publication number:
- EP3962473
- PCT Application Number:
- CA2020050588
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP208015495
- PCT Publication Number:
- WO2020223800
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- FORMULATION FOR PAIN MANAGEMENT COMPRISING TETRAHYDROCANNABINOL (THC), CANNABICHROMENE (CBC) AND CANNABIDIOL (CBD) AT A GIVEN RATIO
- French Title of Invention:
- FORMULATION POUR LE TRAITEMENT DE LA DOULEUR COMPRENANT DU TÉTRAHYDROCANNABINOL (THC), DU CANNABICHROMÈNE (CBC) ET DU CANNABIDIOL (CBD) DANS UN RAPPORT DONNÉ
- German Title of Invention:
- FORMULIERUNG ZUR SCHMERZBEHANDLUNG MIT TETRAHYDROCANNABINOL (THC), CANNABICHROMEN (CBC) UND CANNABIDIOL (CBD) IN EINEM BESTIMMTEN VERHÄLTNIS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 23/08/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/09/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 24/07/2024
- Unitary Effect Registration Date:
- 02/09/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 01/05/2020
- Grant date:
- 24/07/2024
- EP Publication Date:
- 09/03/2022
- PCT Publication Date:
- 12/11/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/07/2024
- EP B1 Publication Date:
- 24/07/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 01/05/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/07/2024
- Name:
- Zyus Life Sciences Inc.
- Address:
- 204 - 407 Downey Road, Saskatoon SK S7N 4L8, Canada (CA)
Inventor
- Name:
- ZETTL, Brenton Harold
- Address:
- Canada (CA)
Priority
1
- Priority Number:
- 201962842696 P
- Priority Date:
- 03/05/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 202063011508 P
- Priority Date:
- 17/04/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/352; A61K 31/05; A61P 29/00; C07C 39/23; C07D 311/58; C07D 311/80;
Publication
European Patent Bulletin
1
- Issue number:
- 202430
- Publication date:
- 24/07/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202440
- Publication date:
- 02/10/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202440
- Publication date:
- 02/10/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|